Insight Report 3 minutes PremiumElizabeth Arden (RDEN) 2Q16 Results: Misses EPS by $0.50 and Misses on Revenue Coresight Research February 4, 2016 Executive Summary Elizabeth Arden reported 2Q16 revenues of $316.2 million, a decrease of 5.2% from the year-ago quarter and missing the consensus estimate of $340.9 million. Excluding currency effects, sales were down 1%. Diluted non-GAAP EPS was $0.10, below the consensus estimate of $0.60. Sales of Elizabeth Arden branded products led growth, increasing by 3%. The growth was driven by higher fragrance and skin care sales, which increased by 8% and 2%, respectively. Management expects foreign currency headwinds to negatively impact full-year net sales growth by approximately 3.75%. In November 2015, the company had estimated a 3% negative impact. Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: Countdown to China’s Singles’ Day 2023: Six Months To Go—What Brands and Retailers Should Know in Advance of the Shopping FestivalEarnings Insights 4Q22, Week 3: CVS and L’Oréal Report Strong Sales Momentum; Capri, Coty and VF Corp See DeclinesMarch 2023 US Retail Traffic and In-Store Metrics: Store-Based Sales and Traffic Growth Decelerate FurtherMacy’s $5.8 Billion Buyout Bid: A Symphony of Risk and Opportunity
